Active Ingredients and Intermediate for Pharmaceuticals

Companies of Active Ingredients and Intermediate for Pharmaceuticals, outsourcing companies, pharmaceutical manufacturing contractees and contractors

I   Market Trend Analysis regarding Active Ingredients and Intermediate for Pharmaceuticals

1. Transition of Market Size of Active Ingredients and Intermediate for Pharmaceuticals (FY2011 - FY2015)
2. Trends of Companies developing Active Ingredients and Intermediate for Pharmaceuticals

• Sales
• Investment
• Quality management
• R&D

3. Challenges for Companies developing Active Ingredients and Intermediate for Pharmaceuticals
4. Market Outlook of Active Ingredients and Intermediate for Pharmaceuticals
5. Estimated Market Size of Active Ingredients and Intermediate for Pharmaceuticals (FY2016 - FY2020)

II   Analysis on Market Strategies Taken by Leading Developers of Active Ingredients and Intermediate for Pharmaceuticals

1. Business Outline
2. Recent Requests from Manufacturers
3. Trends in R&D
4. Trends in Production and Quality Management
5. Sales Trends
6. Future Market Strategies
7. Promising Contractor Categories and Business/Estimated Demands

III   Strategies of Contract Manufacturing of Active Ingredients and Intermediate for Pharmaceuticals

1. Thoughts and Business Positioning towards Outsourcing of Active Ingredients and Intermediate for Pharmaceuticals
2. What to Outsource in Business of Active Ingredients and Intermediate for Pharmaceuticals
3. Criteria to Select Outsourcing Companies in the Business of Active Ingredients and Intermediate for Pharmaceuticals
4. Challenges in Outsourcing Business of Active Ingredients and Intermediate for Pharmaceuticals
5. Future Thoughts and Directions in Outsourcing of Active Ingredients and Intermediate for Pharmaceuticals
6. Products that should be Outsourced in Active Ingredients and Intermediate for Pharmaceuticals
7. Standards, Services, Facilities, and Knowledge Needed in Outsourcing Companies for Active Ingredients and Intermediate for Pharmaceuticals
8. Potential of Outsourcing Business for Active Ingredients and Intermediate for Pharmaceuticals

IV   Trend Analysis for Pharmaceutical Contract Manufacturing Market

1. Characteristics and Status of Pharmaceutical Contract Manufacturing
2. Transition of Size of Pharmaceutical Contract Manufacturing Market (FY2009-FY2013)
3. Current Challenges
4. Future Directions

1. Tasks/Technologies/Services that should be Enhanced
2. Future Promising Areas
3. Future Market Outlooks　

5. Forecast of Pharmaceutical Contract Manufacturing Market Size (FY2014 - FY2018)

V   Market Strategies Taken by Leading Companies of Active Ingredients and Intermediate for Pharmaceuticals

13 Enterprises

VI   Profiles of Leading Companies of Active Ingredients and Intermediate for Pharmaceuticals

88 Enterprises

VII   Other Related Market